A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT06196775 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06196775
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-31
- Primary completion
- 2026-01-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.